Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Tie2 regulates endocardial sprouting and myocardial trabeculation
Xianghu Qu, Cristina Harmelink, H. Scott Baldwin
Xianghu Qu, Cristina Harmelink, H. Scott Baldwin
View: Text | PDF
Research Article Cardiology Development

Tie2 regulates endocardial sprouting and myocardial trabeculation

  • Text
  • PDF
Abstract

The ang1-tyrosine kinase with immunoglobulin-like and EGF-like domains 2 (Tie2) pathway is required for normal vascular development, but its molecular effectors are not well-defined during cardiac ontogeny. Here, we show that endocardial-specific attenuation of Tie2 results in midgestation lethality due to heart defects associated with a hyperplastic but simplified trabecular meshwork (fewer but thicker trabeculae). Reduced proliferation and production of endocardial cells following endocardial loss of Tie2 results in decreased endocardial sprouting required for trabecular assembly and extension. The hyperplastic trabeculae result from enhanced proliferation of trabecular cardiomyocytes, which is associated with upregulation of bone morphogenetic protein 10, increased retinoic acid (RA) signaling, and extracellular signal-regulated protein kinases 1 and 2 hyperphosphorylation in the myocardium. Intriguingly, myocardial phenotypes in conditional knockout hearts could be partially rescued by inhibiting in utero RA signaling with pan-RA receptor antagonist BMS493. These findings reveal 2 complementary functions of endocardial Tie2 during ventricular chamber formation: ensuring normal trabeculation by supporting endocardial cell proliferation and sprouting and preventing hypertrabeculation via suppression of RA signaling in trabecular cardiomyocytes.

Authors

Xianghu Qu, Cristina Harmelink, H. Scott Baldwin

×

Figure 7

Myocardial phenotypes in Tie2-cko hearts were partially rescued by inhibiting in utero RA signaling with BMS493 treatment.

Options: View larger image (or click on image) Download as PowerPoint
Myocardial phenotypes in Tie2-cko hearts were partially rescued by inhib...
(A) qPCR analysis of genes associated with the RA signaling pathway in E11.5 hearts revealed elevated RA signaling following endocardial loss of Tie2. (B and C) Immunostaining of control and Tie2-cko heart sections at E9.5 for Crabp2 showing elevated Crabp2 expression in mutant CMs. (D–F) Gross images of in utero BMS493 (pan-RA receptor antagonist)-treated Tie2+/fl (D), Tie2-cko/R (E, rescued group) and Tie2-cko/P (F, poorly rescued group) embryos at E14.0. Note that dorsal edema (arrow) was common in all mutant embryos, but pericardial effusions (arrowhead) were usually not obvious in the rescued group. (G–I) Heart sections of BMS493-treated Tie2+/fl (G), Tie2-cko/R (H), and Tie2-cko/P (I) embryos at E14.0 were stained with troponin T (red) and endomucin (green) antibodies. (J–L) Quantification of trabecular myocardium complexity (trabeculae density and thickness) and compact myocardium thickness from E11.5–E14.0. The trabeculae in the Tie2-cko rescued group were still thicker than those of BMS493-treated controls but much thinner than those of the Tie2-cko poorly rescued embryos, which were similar to the untreated Tie2-cko embryos. However, the defects on the density of trabeculae and thickness of compact wall and simplification of endocardium in the Tie2-cko rescued group were not significantly improved. (M and N) BrdU pulse labeling and immunostaining showed a little more BrdU-positive (red) CMs, stained with troponin T (green) in the trabecular zone of BMS493-treated Tie2-cko embryos (N) at E11.5 than those in the treated controls (M). (O) Quantification of BrdU-positive nuclei as a percentage of total nuclei in myocardium indicated that BMS493-treated Tie2-cko embryos displayed slightly higher proliferation rates of CMs in the trabecular zone at E11.5. Scale bars: G–I, 100 μm; others, 50 μm. A representative of more than 10 images was chosen for each panel; n = 3 (A) or 6 (J–L and O) per group. *P < 0.05; **P < 0.01, Student’s t test (A) and 2-way ANOVA (J–L and O).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts